BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11840284)

  • 1. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
    Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
    Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
    Zangenberg M; Grubach L; Aggerholm A; Silkjaer T; Juhl-Christensen C; Nyvold CG; Kjeldsen E; Ommen HB; Hokland P
    Eur J Haematol; 2009 Nov; 83(5):439-48. PubMed ID: 19563517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
    Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
    Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
    Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics.
    Roche J; Zeng C; Barón A; Gadgil S; Gemmill RM; Tigaud I; Thomas X; Drabkin HA
    Leukemia; 2004 Jun; 18(6):1059-63. PubMed ID: 15085154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
    Larramendy ML; Niini T; Elonen E; Nagy B; Ollila J; Vihinen M; Knuutila S
    Haematologica; 2002 Jun; 87(6):569-77. PubMed ID: 12031912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
    Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
    Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
    Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.
    Thorsteinsdottir U; Kroon E; Jerome L; Blasi F; Sauvageau G
    Mol Cell Biol; 2001 Jan; 21(1):224-34. PubMed ID: 11113197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations.
    Skvarova Kramarzova K; Fiser K; Mejstrikova E; Rejlova K; Zaliova M; Fornerod M; Drabkin HA; van den Heuvel-Eibrink MM; Stary J; Trka J; Starkova J
    J Hematol Oncol; 2014 Dec; 7():94. PubMed ID: 25539595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
    Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
    Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia.
    Grubach L; Juhl-Christensen C; Rethmeier A; Olesen LH; Aggerholm A; Hokland P; Ostergaard M
    Eur J Haematol; 2008 Aug; 81(2):112-22. PubMed ID: 18410541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Expression of HOXA5 and HOXA9 in AML.
    Zhao P; Tan L; Ruan J; Wei XP; Zheng Y; Zheng LX; Jiang WQ; Fang WJ
    Asian Pac J Cancer Prev; 2015; 16(9):3941-4. PubMed ID: 25987065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.